221 related articles for article (PubMed ID: 28975987)
21. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
Tan J; Yang L
Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
[TBL] [Abstract][Full Text] [Related]
22. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
24. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
25. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.
Li J; Wei L
Biomed Pharmacother; 2019 Jan; 109():519-529. PubMed ID: 30399588
[TBL] [Abstract][Full Text] [Related]
27. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
28. c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer.
Zhang E; Li W; Yin D; De W; Zhu L; Sun S; Han L
Tumour Biol; 2016 Mar; 37(3):4007-15. PubMed ID: 26482621
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
30. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
31. Increased levels of long noncoding RNA LINC00691 correlate with poor prognosis in non-small-cell lung cancer patients.
Xie Y; Hu X
J Clin Lab Anal; 2020 Aug; 34(8):e23357. PubMed ID: 32420681
[TBL] [Abstract][Full Text] [Related]
32. The NmrA-like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial-mesenchymal transition.
Wu XC; Wang SH; Ou HH; Zhu B; Zhu Y; Zhang Q; Yang Y; Li H
Chem Biol Drug Des; 2017 Sep; 90(3):456-463. PubMed ID: 28245089
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA
Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X
Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484
[No Abstract] [Full Text] [Related]
35. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
Pan GF; Zhou XF; Zhao JP
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
[No Abstract] [Full Text] [Related]
36. Long non-coding RNA HNF1A-AS1 up-regulation in non-small cell lung cancer correlates to poor survival.
Ma YF; Liang T; Li CR; Li YJ; Jin S; Liu Y
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4858-4863. PubMed ID: 27981551
[TBL] [Abstract][Full Text] [Related]
37. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
Gharabaghi MA
Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer.
Zhao QS; Li L; Zhang L; Meng XW; Li LL; Ge XF; Li ZP
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3031-4. PubMed ID: 27460731
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.
Zhang Y; Zhao Y; Sun S; Liu Z; Zhang Y; Jiao S
Tumour Biol; 2016 Aug; 37(8):10155-60. PubMed ID: 26831656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]